Friday, February 16, 2024 — Can we prevent retinopathy by improving mitochondrial metabolism? Our 2023-24 Doheny Distinguished Lecture Series February lecture will be delivered by Lois Smith, MD, PhD, Professor of Ophthalmology at Boston Children’s Hospital and Harvard Medical
Doheny Eye Institute acknowledges with gratitude the following organizations for their participation: Educational Grantors Genentech, a member of the Roche Group • Iveric Bio Regeneron • REGENXBIO Inc. • Zeiss ExhibitorsAlcon • Apellis PharmaceuticalsDutch Ophthalmic USA • Coherus BioSciences
Doheny Distinguished Lecture Series January 2024 - "Genetic discoveries that led to the contrast theory of myopia and the development of Diffusion Optic Technology spectacles" featuring Maureen Neitz, PhD, Ray and Grace Hill Endowed Chair in Ophthalmology and Director of Graduate Program in Neuroscience, University of Washington
Doheny Distinguished Lecture Series December 2023 featuring Valerio Carelli and Chiara La Morgia
Register for the 5th Annual Doheny-UCLA International Glaucoma Symposium to be held at Doheny Eye Institute on Saturday, September 30, 2023. This will be a half-day conference featuring dynamic presentations covering imaging pearls, medical & surgical management with MIGS vs traditional approaches, cataract surgery and glaucoma, as well as complex cases (diagnostic and management dilemmas). […]
Dr. Maya Koronyo-Hamaoui is Professor of Neurosurgery and Professor of Biomedical Sciences at Cedars-Sinai, Los Angeles. Her primary research focus is on early diagnosis and immune-based therapies for Alzheimer's disease (AD). The Koronyo-Hamaoui Laboratory has shown that the hallmark pathology of AD, amyloid-β protein (Aβ) plaque, is present in the retina of human patients beginning at early stages. A unique approach has been developed in her lab to detect plaques in the retina of live rodent models by a noninvasive optical retinal imaging. This innovation unveils new possibilities for investigation of Alzheimer's pathology in the retina. It may also facilitate early diagnosis and noninvasive monitoring of disease progression.
Dr. Maya Koronyo-Hamaoui is Professor of Neurosurgery and Professor of Biomedical Sciences at Cedars-Sinai, Los Angeles. Her primary research focus is on early diagnosis and immune-based therapies for Alzheimer's disease (AD). The Koronyo-Hamaoui Laboratory has shown that the hallmark pathology of AD, amyloid-β protein (Aβ) plaque, is present in the retina of human patients beginning at early stages. A unique approach has been developed in her lab to detect plaques in the retina of live rodent models by a noninvasive optical retinal imaging. This innovation unveils new possibilities for investigation of Alzheimer's pathology in the retina. It may also facilitate early diagnosis and noninvasive monitoring of disease progression.
All friends, colleagues, family, and alumni are invited to celebrate this year’s honoree, Mark S. Borchert, MD, of CHLA. Each year the Doheny Professional Association honors a member as the “Distinguished Alumnus” for achievement and commitment to the advancement of ophthalmic research, education, or patient care. The annual dinner is immediately following the conference. RSVPs can be made at doheny.org/alumni23.
